Table 7.

Correlation between patients’ serum atherogenic index and cholesterol profiles during the trial.

Variables	Control Group			Experimental Group
	Cholesterol, mg/dL
	Total	LDL	HDL	Total	LDL	HDL
	Difference T0–T1 (inpatient period)
AI (rel. un.)
Correlation coefficient	0.525 *	0.476 *	0.003	0.600 *	0.507 *	−0.238
Significance (two–tailed)	0.025	0.046	0.990	0.009	0.032	0.341
	Difference T0–T2 (outpatient period)
AI (rel. un.)
Correlation coefficient	0.670 *	0.703 *	0.020	0.740 *	0.810 *	0.071
Significance (two–tailed)	0.002	0.001	0.938	0.001	<0.001	0.779

* Statistically significant.